NCT00486330 - Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

HIV Infections

Interventions

DRUG

Buprenorphine, Tipranavir and ritonavir

After determining buprenorphine/naloxone pharmacokinetics over a 24-hour period, tipranavir/ritonavir and buprenorphine/naloxone will be coadministered for 7 days.

Trial Locations (1)

06510

Yale University School of Medicine AIDS Program, New Haven